Bjork Elisabeth 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Purchase
Common Stock
2026-01-02$3.44/sh+10,000$34,400→ 50,000 total
Footnotes (1)
- [F1]Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.